LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis
A Randomized, Single-Blind, Active Control, 18-Week Study to Evaluate the Safety and Efficacy of A New Twice-Daily, Topically Applied LCD Solution vs. Calcipotriol Cream for the Treatment of Adult Subjects With Moderate Plaque Psoriasis
  • Phase

  • Study Type

  • Status

    Completed No Results Posted
  • Study Participants

The purpose of this study is to compare the safety and effectiveness of a new topical LCD solution and a commercially available calcipotriol (Vitamin D) cream in reducing the symptoms of plaque psoriasis and improving the quality of life in adults.
Study Started
Jan 31
Primary Completion
Nov 30
Study Completion
Nov 30
Last Update
Nov 19

Drug LCD

2 applications / day for 12 weeks

Drug calcipotriol

2 applications / day for 12 weeks

  • Other names: Dovonex Cream (50 mcg/g 0.005%)

1 Experimental

LCD Solution: 2 applications / day

2 Active Comparator

Calcipotriol cream: 2 applications / day


Inclusion Criteria:

18 years of age or older
able and willing to provide written informed consent
diagnosed with chronic plaque psoriasis
3% to 15% body surface area involved
in good general health

Exclusion Criteria:

other current treatments for psoriasis
renal or liver dysfunction
pregnant or nursing
No Results Posted